Jennifer Doudna company

Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for ...

Jennifer Doudna company

Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases. ,How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna.

相關軟體 Vivaldi 資訊

Vivaldi
從 Opera 的創造者,一個 Vivaldi 瀏覽器是快速的,但也是一個功能豐富的瀏覽器,高度靈活,並把用戶放在第一位。一個為你製作的瀏覽器。最後,你可以沖浪你的方式.63235896 Vivaldi 網頁瀏覽器適應你,而不是相反。你喜歡瀏覽器標籤放在窗口的底部還是側面?也許你更喜歡不同的地址欄位置?使用 Vivaldi 瀏覽器,您將能夠自定義所有更多內容,如鍵盤快捷方式,鼠標手勢等。選擇版本:... Vivaldi 軟體介紹

Jennifer Doudna company 相關參考資料
A day with Jennifer Doudna: Trying to keep up with one

2020年3月8日 — Doudna is the executive director of the IGI, an academic initiative run by UC Berkeley and UC San Francisco with the aim of fulfilling the ...

https://cen.acs.org

Caribou Biosciences | Developing Sophisticated Allogeneic ...

Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.

https://www.cariboubio.com

How CRISPR gene editing will treat diseases in future - CNBC

How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna.

https://www.cnbc.com

Intellia Therapeutics Congratulates Co-Founder Jennifer ...

2020年10月7日 — Intellia Therapeutics Congratulates Co-Founder Jennifer Doudna On Winning the 2020 Nobel Prize in Chemistry for Inventing the Revolutionary ...

https://ir.intelliatx.com

Jennifer Doudna - Co-Founder @ Mammoth Biosciences

Jennifer Doudna has 6 current jobs including Co-Founder at Caribou Biosciences , Co-Founder at Scribe Therapeutics , and Co-Founder at Mammoth Biosciences .

https://www.crunchbase.com

Jennifer Doudna - Forbes

Doudna is a director at Johnson & Johnson and has pivotal research projects with Biogen, Pfizer, Roche, and Darpa. On forbes lists. 50 Over 50 2021.

https://www.forbes.com

Jennifer Doudna - Wikipedia

In 2017, Doudna co-founded Mammoth Biosciences, a San Francisco-based bioengineering tech startup. Initial funding raised $23 million, with a series B round of ...

https://en.wikipedia.org

Jennifer Doudna's New Gene Editing Company Launches

2020年10月6日 — Jennifer Doudna is the Co-founder of Scribe Therapeutics, a new company developing CRISPR-based ... [+] genetic medicines. She recently received ...

https://www.forbes.com

Jennifer Doudna-founded CRISPR biotech raises new cash to ...

2021年9月10日 — Mammoth Biosciences, a biotech startup co-founded by CRISPR pioneer Jennifer Doudna, is expanding its efforts to turn the gene editing ...

https://www.biopharmadive.com

The latest Jennifer Doudna startup launches with a Biogen ...

The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased ...

https://endpts.com